BIOMAT Database Logo BIOMAT Database Logo

The physiologic availability of solid dosage forms of phenylbutazone. II. Correlation of in vivo physiologic availability and in vitro dissolution parameters. 1971

R J Withey, and H Feng, and D Cook, and G R Van Petten, and H F Lettau

UI MeSH Term Description Entries
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D010653 Phenylbutazone A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS. Diphenylbutazone,Fenilbutazon,Butacote,Butadion,Butadione,Butapirazol,Butapyrazole,Butazolidin
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D001702 Biopharmaceutics The study of the physical and chemical properties of a drug and its dosage form as related to the onset, duration, and intensity of its action. Pharmaceutics,Pharmaceutic
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities
D013607 Tablets Solid dosage forms, of varying weight, size, and shape, which may be molded or compressed, and which contain a medicinal substance in pure or diluted form. (Dorland, 28th ed) Tablet
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

R J Withey, and H Feng, and D Cook, and G R Van Petten, and H F Lettau
In vitro dissolution rates of aminorex dosage forms and their correlation with in vivo availability.
December 1969, Journal of pharmaceutical sciences,
R J Withey, and H Feng, and D Cook, and G R Van Petten, and H F Lettau
Dissolution of drugs from solid dosage forms. II. In vitro and in vivo dissolutions.
October 1979, JPMA. The Journal of the Pakistan Medical Association,
R J Withey, and H Feng, and D Cook, and G R Van Petten, and H F Lettau
In vitro-in vivo correlation and dissolution studies with oral theophylline dosage forms.
February 1985, Journal of pharmaceutical sciences,
R J Withey, and H Feng, and D Cook, and G R Van Petten, and H F Lettau
"In vitro" dissolution tests for solid oral dosage forms.
September 1977, Bollettino chimico farmaceutico,
R J Withey, and H Feng, and D Cook, and G R Van Petten, and H F Lettau
Dissolution rate for predicting physiological availability of drugs from solid dosage forms.
February 1968, Irish journal of medical science,
R J Withey, and H Feng, and D Cook, and G R Van Petten, and H F Lettau
Correlation between dissolution characteristics and absorption of methaqualone from solid dosage forms.
April 1976, Journal of pharmaceutical sciences,
R J Withey, and H Feng, and D Cook, and G R Van Petten, and H F Lettau
In vitro and in vivo availability of spironolactone from oral dosage forms.
November 1976, Journal of pharmaceutical sciences,
R J Withey, and H Feng, and D Cook, and G R Van Petten, and H F Lettau
Dissolution of theophylline from sustained-release dosage forms and correlation with saliva bioavailability parameters.
October 1987, Journal of pharmaceutical sciences,
R J Withey, and H Feng, and D Cook, and G R Van Petten, and H F Lettau
Study on dissolution and absorption of four dosage forms of isosorbide mononitrate: level A in vitro-in vivo correlation.
October 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V,
R J Withey, and H Feng, and D Cook, and G R Van Petten, and H F Lettau
The influence of crushing amorphous solid dispersion dosage forms on the in-vitro dissolution kinetics.
January 2020, International journal of pharmaceutics,
Copied contents to your clipboard!